Commentary. From scarcity to abundance: Pandemic vaccines and other agents for "have not" countries

Journal of Public Health Policy

Volumn 28, Issue 3, 2007, Pages 322-340

  Fedson, David S ^a   Dunnill, Peter ^b  

^a University College London ^*  (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

DEVELOPING COUNTRY; DRUG DESIGN; DRUG INDUSTRY; ECONOMICS; EPIDEMIC; HEALTH SERVICE; HUMAN; IMMUNOLOGY; INDONESIA; INFECTION CONTROL; INFLUENZA VIRUS A H5N1; INTERNATIONAL COOPERATION; ORGANIZATION AND MANAGEMENT; REVIEW; WORLD HEALTH ORGANIZATION;

COMMUNICABLE DISEASE CONTROL; DEVELOPING COUNTRIES; DISEASE OUTBREAKS; DRUG DESIGN; DRUG INDUSTRY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INDONESIA; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INTERNATIONALITY; WORLD HEALTH ORGANIZATION;

EID: 34548293165     PISSN: 01975897     EISSN: 1745655X     Source Type: Journal    
DOI: 10.1057/palgrave.jphp.3200147     Document Type: Review

References (44)

1. Reuters. Indonesia says WHO must set rules on H5N1 sharing, 2 February 2007.
2. MacKenzie D. Poor countries hold out for bird vaccine. New Scientist, 16 February 2007. Available at http://www.newscientist.com/ article.ns?id=mg19325914.600&print=true.
3. World Health Organization. Pandemic Influenza Vaccine: WHO and International Community Make Progress Towards Ensuring Access of Developing Countries, 22 March 2007. Available at http://www.who.int/mediacentre/news/ releases/2007/pr21/en/print.html.
4. World Health Organization. Indonesia to Resume Sharing H5N1 Avian Influenza Virus Samples Following a WHO Meeting in Jakarta, 27 March 2007. Available at http://www.who.int/mediacentre/news/releases/2007/pr09/en/print. html.
5. Sixtieth World Health Assembly. Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to Vaccines and Other Benefits. WHA 60.28, 23 May 2007. Available at http://www.int/csr/don/archive/disease/ influenza/A60_28-en.pdf.
6. Fedson DS. Preparing for pandemic vaccination: an international policy agenda for vaccine development. J Public Health Pol. 2005;26:4-29.
7. Fedson DS. Vaccine development for an imminent pandemic: why we should worry, what we must do. Hum Vaccin. 2006;2:38-42.
8. Fedson DS, Dunnill P. New approaches to confronting an imminent influenza pandemic. Perm J. 2007;11:63-9.
9. UN System Influenza Coordinator & World Bank. Responses to avian and human influenza threats: progress, analysis and recommendations, January-June 2006. Available at http://siteresources.worldbank.org/INTTOPAVIFLUResources/ UNSIC_Report_Vienna_Final.pdf.
10. World Health Organization. WHO Global Programme on Influenza. Vaccine Research and Development, Current Status, November 2005.
11. Stephenson I, Gust I, Kieny MP, Pervikov Y. Development and evaluation of influenza pandemic vaccines. Lancet Infect Dis. 2006;6:71-2.
12. Stephenson I, Gust I, Pervikov Y, Kieny MP. Development of vaccines against influenza H5. Lancet Infect Dis. 2006;6:458-60.
13. Kieny MP, Costa A, Hombach J, Carrasco P, Pervikov Y, Salisbury D, et al. A global pandemic influenza vaccine action plan. Vaccine. 2006;24:6367-70.
14. World Health Organization. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines. Wkly Epidemiol Rec. 2007;82:164-7.
15. Subbarao K, Joseph T. Scientific barriers to developing vaccines against avian influenza viruses. Nat Rev Immunol. 2007;7:267-78.
16. Hennessy AV, Davenport FM. Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule. Public Health Rep. 1961;76:411-9.
17. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M. Safety and immunogenicity of an inactivated sub-virion influenza A (H5N1) vaccine. N Engl J Med. 2006;354:1343-51.
18. US Department of Health and Human Services. Food and Drug Administration. Guidance for Industry. Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines. May 2007. Available at http://www.fda.gov/cber/ gdlns/panfluvac.htm.
19. Stohr K, Kieny MP, Wood D. Influenza pandemic vaccines: how to ensure a low-cost, low-dose option. Nat Rev Immunol. 2006;4:565-6.
20. Centers for Disease Control and Prevention. Interim Pre-pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States - Early, Targeted, Layered Use of Nonpharmaceutical Interventions. Washington, DC: Centers for Disease and Control and Prevention, US Department of Health and Human Services; 2007, February. Available at www.pandemicflu.gov/plan/community/community_mitigation.pdf.
21. The Macroepidemiology of Influenza Vaccination (MIV) Study Group. The macroepidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine. 2005;23:5133-43.
22. MacInnis L. Shortage of pandemic flu vaccine to last for five years. Reuters, 23 May 2007.
23. Schnirring L. WHO confirms backlog of 15 Indonesian H5N1 cases, May 16, 2007, CIDRAP News. Available at http://www/cidrap.umn.edu/cidrap/cntent/ influenza/panflu/news/may1607indonesia.html.
24. World Health Organization. Global Health Partners Mobilize to Counter Yellow Fever US $58 million GAVI contribution to prevent highly contagious disease in 12 West African nations. 16 May 2007. Available at http://.www.who.int/mediacentre/news/releases/2007/pr23/en/prit.html.
25. Peiris JSM, de Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Crit Microbiol Rev. 2007;20:243-67.
26. Suguitan Jr AL, McAuliffe J, Mills KL, Jin H, Duke G, Lu B, et al. Live attenuated influenza A H5N1 candidate vaccine provides broad cross-protection in mice and ferrets. PLoS Medicine. 2006;3:e360. Available at www.plosmedicine.org.
27. Karron R, Callahan K, Luke C, Thurman B, Coelingh K, Jin H, et al. Phase I evaluation of live attenuated H9N2 and H5N1 ca reassortant vaccines in healthy adults. 3rd WHO Meeting on Evaluation of Pandemic Influenza Prototype Vaccines in Clinical Trials, Geneva, Switzerland, 15-16 February 2007.
28. Treanor JJ, Schiff GM, Couch RB, Cate TR, Brady RC, Hay CM, et al. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza virus hemagglutinin vaccine in elderly adults. J Infect Dis. 2006;193:1223-8.
29. Treanor JJ, Schiff GM, Hayden FG, Brady RC, Hay CM, Meyer AL, et al. Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine. JAMA. 2007;297:1577-82.
30. Hoyt K. Vaccine innovation: lessons from World War II. J Public Health Pol. 2006;27:38-57.
31. Infectious Diseases Society of America. Pandemic and Seasonal Influenza. Principles for U.S. action January 2007. Available at http://www.idsociety.org.
32. Rhodes R. The Making of the Atomic Bomb. New York: Simon and Schuster; 1986.
33. Norris RS. Racing for the Bomb. General Leslie R. Groves, the Manhattan Project's Indispensable Man. South Royalton VT: Stepforth Press; 2002, p. 170.
34. US Department of Energy. Strategic Petroleum Reserve Inventory. Available at http://www.spr.doe.gov/eports/dtr.htm.
35. Levine R. The cure for Asian flu. Biosecur Bioterror. 2006;4:228-30.
36. Fedson DS. Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clin Infect Dis. 2006;43:199-205.
37. Liao JK, Laufs U. Pleiotropic effect of statins. Annu Rev Pharmacol Toxicol. 2005;45:89-118.
38. Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis. 2007;7:358-68.
39. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chan TN, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006;12:1203-7.
40. Kash JC, Tumpey TM, Proll SC, Cartar V, Perwitasari O, Thomas MJ, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature. 2006;443:578-81.
41. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature. 2007;445:319-23.
42. Weill Cornell Medical College students help change global health policy, 21 May, 2007. Available at http://www.bigmedium.med.cornell.edu/cgi-bin/ moxiebin/bm_tools.cgi?print=1196;s=2_14;site=2.
43. Murray CJL, Lopez AD, Chin B, Feehan D, Hill KH. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet. 2006;368:2211-8.
44. Reynolds I. Health alert over Tamiflu, bird flu spreads in Myanmar. Reuters, 21 March 2007. Available at http://www.alertnet.org/thenews/ newsdesk/SP39628.htm.